H4: the lot was manufactured on july 7, 2022, to july 8, 2022.H10: the device was received for evaluation.A visual inspection was performed which noted that the bladder from the sample had been ruptured to drain the drug fluid before returning the sample.Therefore, a functional flow test could not be performed.An examination of the tubing line and flow restrictor was performed which showed no evidence of a blockage.A blockage such as drug precipitate or air bubbles would typically be root causes of no flow after fill; however, no evidence of a blockage was found from the tubing line and flow restrictor in the sample.The reported condition was not verified.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
|